{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:22:08Z","timestamp":1789420928067,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T00:00:00Z","timestamp":1447977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s10840-015-0077-2","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T07:39:37Z","timestamp":1448005177000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?"],"prefix":"10.1007","volume":"45","author":[{"given":"Jorge","family":"Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Baldinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goodman-Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krysthel","family":"Engstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina R.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjani","family":"Golive","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarivinoth","family":"Rangasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Makkiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Krumerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario J.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Ferrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"issue":"10","key":"77_CR1","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJMra032426","volume":"350","author":"DM Roden","year":"2004","unstructured":"Roden, D. M. (2004). Drug-induced prolongation of the QT interval. New England Journal of Medicine, 350(10), 1013\u20131022.","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"77_CR2","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1053\/euhj.2000.2249","volume":"21","author":"W Haverkamp","year":"2000","unstructured":"Haverkamp, W., et al. (2000). The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. European Heart Journal, 21(15), 1216\u20131231.","journal-title":"European Heart Journal"},{"issue":"Suppl","key":"77_CR3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jelectrocard.2004.08.030","volume":"37","author":"S Luo","year":"2004","unstructured":"Luo, S., et al. (2004). A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. Journal of Electrocardiology, 37(Suppl), 81\u201390.","journal-title":"Journal of Electrocardiology"},{"issue":"11\u201312","key":"77_CR4","first-page":"467","volume":"4","author":"S Torigoe","year":"1992","unstructured":"Torigoe, S., et al. (1992). p53 gene mutation in primary human renal cell carcinoma. Oncology Research, 4(11\u201312), 467\u2013472.","journal-title":"Oncology Research"},{"issue":"7","key":"77_CR5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/S0735-1097(96)00377-4","volume":"28","author":"C Antzelevitch","year":"1996","unstructured":"Antzelevitch, C., et al. (1996). Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. Journal of the American College of Cardiology, 28(7), 1836\u20131848.","journal-title":"Journal of the American College of Cardiology"},{"key":"77_CR6","volume-title":"National Center for Health Statistics. Increases in poisoning and methadone-related deaths: United States, 1999\u20132005","author":"LA Fingerhut","year":"2008","unstructured":"Fingerhut, L. A. (2008). National Center for Health Statistics. Increases in poisoning and methadone-related deaths: United States, 1999\u20132005."},{"key":"77_CR7","volume-title":"Data on substance abuse treatment facilities. BHSIS Series S-73, HHS Publication No. (SMA) 14\u2013489","author":"Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS) 2013","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration, National Survey of Substance Abuse Treatment Services (N-SSATS) 2013. (2014). Data on substance abuse treatment facilities. BHSIS Series S-73, HHS Publication No. (SMA) 14\u2013489. Rockville, MD: Substance Abuse and Mental Health Services Administration."},{"key":"77_CR8","volume-title":"BHSIS Series S-65, HHS. Publication No. (SMA) 14\u20134807","author":"Substance Abuse and Mental Health Services Administration, 2011 Opioid Treatment Program Survey: data on substance abuse treatment facilities with OTPs","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration, 2011 Opioid Treatment Program Survey: data on substance abuse treatment facilities with OTPs. (2013). BHSIS Series S-65, HHS. Publication No. (SMA) 14\u20134807. Rockville, MD: Substance Abuse and Mental Health Services. Administration."},{"issue":"11","key":"77_CR9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2008.12.014","volume":"53","author":"PM Rautaharju","year":"2009","unstructured":"Rautaharju, P. M., Rautaharju, P. M., et al. (2009). AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Journal of the American College of Cardiology, 53(11), 982\u2013991.","journal-title":"Journal of the American College of Cardiology"},{"issue":"949","key":"77_CR10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/pgmj.2004.022988","volume":"80","author":"R Brown","year":"2004","unstructured":"Brown, R., et al. (2004). Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgraduate Medical Journal, 80(949), 654\u2013659.","journal-title":"Postgraduate Medical Journal"},{"issue":"12","key":"77_CR11","first-page":"1657","volume":"97","author":"MU Sani","year":"2005","unstructured":"Sani, M. U., & Okeahialam, B. N. (2005). QTc interval prolongation in patients with HIV and AIDS. Journal of the National Medical Association, 97(12), 1657\u20131661.","journal-title":"Journal of the National Medical Association"},{"issue":"8","key":"77_CR12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/cid\/cit467","volume":"57","author":"G Vallecillo","year":"2013","unstructured":"Vallecillo, G., et al. (2013). Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Clinical Infectious Diseases, 57(8), 1189\u20131194.","journal-title":"Clinical Infectious Diseases"},{"key":"77_CR13","unstructured":"General Accountability Office. Methadone-associated overdose deaths: factors contributing to increased deaths and efforts to prevent them. Available at: http:\/\/www.gao.gov\/products\/GAO-09-341 . Accessed june 2014"},{"issue":"4","key":"77_CR14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/10550887.2011.610704","volume":"30","author":"MC Haigney","year":"2011","unstructured":"Haigney, M. C. (2011). First, do no harm: QT interval screening in methadone maintenance treatment. Journal of Addictive Diseases, 30(4), 309\u2013312.","journal-title":"Journal of Addictive Diseases"},{"key":"77_CR15","unstructured":"Rosemont Pharmaceuticals Limited. Methadone hydrochloride DTF 1\u00a0mg\/1\u00a0ml oral solution. Available at: http:\/\/xpil.medicines.org.uk\/ViewPil.aspx?DocID=22767 . ."},{"issue":"3","key":"77_CR16","first-page":"210","volume":"16","author":"CM Andrews","year":"2009","unstructured":"Andrews, C. M., et al. (2009). Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation. Cardiology Journal, 16(3), 210\u2013217.","journal-title":"Cardiology Journal"},{"issue":"22","key":"77_CR17","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1001\/jama.2008.802","volume":"300","author":"AJ Hall","year":"2008","unstructured":"Hall, A. J., et al. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613\u20132620.","journal-title":"JAMA"},{"key":"77_CR18","volume-title":"Food and Drug Administration, Center for Drug Evaluation and Research. Verispan Total Patient Tracker, Year 2007","author":"Verispan","year":"2008","unstructured":"Verispan. (2008). Food and Drug Administration, Center for Drug Evaluation and Research. Verispan Total Patient Tracker, Year 2007."},{"issue":"4","key":"77_CR19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jbi.2006.10.004","volume":"40","author":"SA Sims","year":"2007","unstructured":"Sims, S. A., Snow, L. A., & Porucznik, C. A. (2007). Surveillance of methadone-related adverse drug events using multiple public health data sources. Journal of Biomedical Informatics, 40(4), 382\u2013389.","journal-title":"Journal of Biomedical Informatics"},{"key":"77_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fphar.2010.00137","volume":"1","author":"LS Grilo","year":"2010","unstructured":"Grilo, L. S., Carrupt, P. A., & Abriel, H. (2010). Stereoselective inhibition of the hERG1 potassium channel. Frontiers in Pharmacology, 1, 137.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"77_CR21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1124\/jpet.102.038240","volume":"303","author":"AN Katchman","year":"2002","unstructured":"Katchman, A. N., et al. (2002). Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. Journal of Pharmacol and Experimental Therapeutics, 303(2), 688\u2013694.","journal-title":"Journal of Pharmacol and Experimental Therapeutics"},{"issue":"1","key":"77_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.285.1.39","volume":"285","author":"M Auriacombe","year":"2001","unstructured":"Auriacombe, M., Franques, P., & Tignol, J. (2001). Deaths attributable to methadone vs buprenorphine in France. JAMA, 285(1), 45.","journal-title":"JAMA"},{"issue":"18","key":"77_CR23","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","volume":"343","author":"RE Johnson","year":"2000","unstructured":"Johnson, R. E., et al. (2000). A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343(18), 1290\u20131297.","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"77_CR24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1046\/j.1360-0443.2002.00215.x","volume":"97","author":"N Lintzeris","year":"2002","unstructured":"Lintzeris, N., et al. (2002). A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal. Addiction, 97(11), 1395\u20131404.","journal-title":"Addiction"},{"issue":"22","key":"77_CR25","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","volume":"167","author":"EF Wedam","year":"2007","unstructured":"Wedam, E. F., et al. (2007). QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Archives of Internal Medicine, 167(22), 2469\u20132475.","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"77_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J069v20n04_02","volume":"20","author":"RL Deamer","year":"2001","unstructured":"Deamer, R. L., et al. (2001). Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). Journal of Addictive Diseases, 20(4), 7\u201314.","journal-title":"Journal of Addictive Diseases"},{"issue":"3","key":"77_CR27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/02791072.1995.10472469","volume":"27","author":"ML Prendergast","year":"1995","unstructured":"Prendergast, M. L., et al. (1995). Levo-alpha-acetylmethadol (LAAM): clinical, research, and policy issues of a new pharmacotherapy for opioid addiction. Journal of Psychoactive Drugs, 27(3), 239\u2013247.","journal-title":"Journal of Psychoactive Drugs"},{"issue":"19","key":"77_CR28","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","volume":"348","author":"SG Priori","year":"2003","unstructured":"Priori, S. G., et al. (2003). Risk stratification in the long-QT syndrome. New England Journal of Medicine, 348(19), 1866\u20131874.","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"77_CR29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.hjr.0000173110.21851.a9","volume":"12","author":"SR Benoit","year":"2005","unstructured":"Benoit, S. R., et al. (2005). Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. European Journal of Cardiovascular Prevention and Rehabilitation, 12(4), 363\u2013368.","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"issue":"2","key":"77_CR30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","volume":"81","author":"MC Sanguinetti","year":"1995","unstructured":"Sanguinetti, M. C., et al. (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell, 81(2), 299\u2013307.","journal-title":"Cell"},{"issue":"2","key":"77_CR31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/oxfordjournals.eurheartj.a061633","volume":"5","author":"JR Milne","year":"1984","unstructured":"Milne, J. R., et al. (1984). Class 1 antiarrhythmic drugs\u2014characteristic electrocardiographic differences when assessed by atrial and ventricular pacing. European Heart Journal, 5(2), 99\u2013107.","journal-title":"European Heart Journal"},{"issue":"16","key":"77_CR32","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1161\/01.CIR.0000014448.19052.4C","volume":"105","author":"P Yang","year":"2002","unstructured":"Yang, P., et al. (2002). Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation, 105(16), 1943\u20131948.","journal-title":"Circulation"},{"issue":"10","key":"77_CR33","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.107.710780","volume":"116","author":"C Newton-Cheh","year":"2007","unstructured":"Newton-Cheh, C., et al. (2007). Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation, 116(10), 1128\u20131136.","journal-title":"Circulation"},{"issue":"10","key":"77_CR34","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.0000027139.42087.B6","volume":"106","author":"N Makita","year":"2002","unstructured":"Makita, N., et al. (2002). Drug-induced long-QT syndrome associated with a subclinical SCN5A mutation. Circulation, 106(10), 1269\u20131274.","journal-title":"Circulation"},{"issue":"4","key":"77_CR35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.99.4.518","volume":"99","author":"SG Priori","year":"1999","unstructured":"Priori, S. G., et al. (1999). Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation, 99(4), 518\u2013528.","journal-title":"Circulation"},{"issue":"4","key":"77_CR36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/01.CIR.99.4.529","volume":"99","author":"SG Priori","year":"1999","unstructured":"Priori, S. G., Napolitano, C., & Schwartz, P. J. (1999). Low penetrance in the long-QT syndrome: clinical impact. Circulation, 99(4), 529\u2013533.","journal-title":"Circulation"},{"issue":"1","key":"77_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","volume":"3","author":"PJ Whelan","year":"2012","unstructured":"Whelan, P. J., & Remski, K. (2012). Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds. J Neurosci Rural Pract, 3(1), 45\u201350.","journal-title":"J Neurosci Rural Pract"},{"issue":"4","key":"77_CR38","first-page":"229","volume":"4","author":"S Mujtaba","year":"2013","unstructured":"Mujtaba, S., Romero, J., & Taub, C. C. (2013). Methadone, QTc prolongation and torsades de pointes: current concepts, management and a hidden twist in the tale? J Cardiovasc Dis Res, 4(4), 229\u2013235.","journal-title":"J Cardiovasc Dis Res"},{"issue":"4","key":"77_CR39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1592\/phco.25.4.611.61020","volume":"25","author":"MJ Krantz","year":"2005","unstructured":"Krantz, M. J., Garcia, J. A., & Mehler, P. S. (2005). Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes. Pharmacotherapy, 25(4), 611\u2013614.","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-015-0077-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-015-0077-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-015-0077-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T02:04:14Z","timestamp":1559268254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-015-0077-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["77"],"URL":"https:\/\/doi.org\/10.1007\/s10840-015-0077-2","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}